12 Jul 2021
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209785
11 Jul 2018
// PHARMA LETTER
https://www.thepharmaletter.com/in-brief/brief-ftc-imposes-conditions-on-amneal-acquisition-of-impax
07 May 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-completes-acquisition-of-generic-products-and-assets-from-amnealimpax-300642867.html
29 Dec 2017
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204963
05 May 2016
// FDA
https://www.pharmacompass.com/pdf/news/indicuss-generic-desipramine-hcl-approved-in-us-as-antidepressant-drug-1462882780.pdf
https://www.pharmacompass.com/pdf/news/amneal-pharms-generic-desipramine-hydrochloride-approved-in-us-for-treatment-of-depression-1458722573.pdf
LOOKING FOR A SUPPLIER?